Claire Gleadhill1, Marlene M Speth2, Isabelle Gengler3, Katie M Phillips3, Lloyd P Hoehle4, David S Caradonna5,6, Stacey T Gray5,7, Ahmad R Sedaghat8. 1. Department of Otolaryngology, University of Arizona College of Medicine, Tucson, AZ, USA. 2. Klinik für Hals-, Nasen-, Ohren- Krankheiten, Hals-und Gesichtschirurgie, Kantonsspital Aarau, Aarau, Switzerland. 3. Department of Otolaryngology-Head and Neck Surgery, Medical Sciences Building, University of Cincinnati College of Medicine, Room 6410, 231 Albert Sabin Way, Cincinnati, OH, 45267-0528, USA. 4. Edward Via College of Osteopathic Medicine-Carolinas, Spartanburg, USA. 5. Department of Otolaryngology, Harvard Medical School, Boston, MA, USA. 6. Division Otolaryngology, Beth Israel Deaconness Medical Center, Boston, MA, USA. 7. Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, MA, USA. 8. Department of Otolaryngology-Head and Neck Surgery, Medical Sciences Building, University of Cincinnati College of Medicine, Room 6410, 231 Albert Sabin Way, Cincinnati, OH, 45267-0528, USA. ahmad.sedaghat@uc.edu.
Abstract
PURPOSE: Chronic rhinosinusitis (CRS) disease burden is associated with pulmonary status in asthmatic CRS patients. Asthma-related emergency department (ED) usage is a predictor of asthma-related mortality. We sought to determine whether measures of CRS disease burden are associated with asthma-related ED usage. METHODS: We prospectively recruited 263 asthmatic CRS patients for this cross-sectional study. CRS burden was measured using the 22-item Sinonasal Outcome Test (SNOT-22), and patient-reported CRS-related antibiotic usage and CRS-related oral corticosteroids usage over the preceding year. Asthma-related ED visits over the prior year were also assessed. RESULTS: Of all participants, 18.6% had at least 1 asthma-related ED visit (mean 0.3 ED visits for the whole cohort). Asthma-related ED usage was associated with SNOT-22 score [adjusted rate ratio (RR) = 1.02, 95% CI 1.01-1.03, p = 0.040] and CRS-related oral corticosteroids usage in the past year (RR = 1.52, 95% CI 1.26-1.83, p < 0.001). From the SNOT-22 score, asthma-related ED usage was only associated with the nasal subdomain score (RR = 1.08, 95% CI 1.03-1.13, p = 0.001). These measures of CRS disease burden could be used with good sensitivity and specificity to detect patients with asthma-related ED usage in the past year, the majority of whom were undertreated for their asthma. CONCLUSIONS: Measures of CRS disease burden are associated with and can be used to detect, patients having asthma-related ED usage. These results further solidify the connection between CRS and asthma disease courses, and also present an opportunity to use CRS disease burden as a tool for identifying-and implementing greater treatment of-patients at highest risk for asthma-related mortality.
PURPOSE:Chronic rhinosinusitis (CRS) disease burden is associated with pulmonary status in asthmatic CRSpatients. Asthma-related emergency department (ED) usage is a predictor of asthma-related mortality. We sought to determine whether measures of CRS disease burden are associated with asthma-related ED usage. METHODS: We prospectively recruited 263 asthmatic CRSpatients for this cross-sectional study. CRS burden was measured using the 22-item Sinonasal Outcome Test (SNOT-22), and patient-reported CRS-related antibiotic usage and CRS-related oral corticosteroids usage over the preceding year. Asthma-related ED visits over the prior year were also assessed. RESULTS: Of all participants, 18.6% had at least 1 asthma-related ED visit (mean 0.3 ED visits for the whole cohort). Asthma-related ED usage was associated with SNOT-22 score [adjusted rate ratio (RR) = 1.02, 95% CI 1.01-1.03, p = 0.040] and CRS-related oral corticosteroids usage in the past year (RR = 1.52, 95% CI 1.26-1.83, p < 0.001). From the SNOT-22 score, asthma-related ED usage was only associated with the nasal subdomain score (RR = 1.08, 95% CI 1.03-1.13, p = 0.001). These measures of CRS disease burden could be used with good sensitivity and specificity to detect patients with asthma-related ED usage in the past year, the majority of whom were undertreated for their asthma. CONCLUSIONS: Measures of CRS disease burden are associated with and can be used to detect, patients having asthma-related ED usage. These results further solidify the connection between CRS and asthma disease courses, and also present an opportunity to use CRS disease burden as a tool for identifying-and implementing greater treatment of-patients at highest risk for asthma-related mortality.
Entities:
Keywords:
Antibiotics; Asthma; Chronic rhinosinusitis; Emergency department usage; SNOT-22; Steroids
Authors: K M Phillips; L P Hoehle; R W Bergmark; A P Campbell; D S Caradonna; S T Gray; A R Sedaghat Journal: Rhinology Date: 2017-09-01 Impact factor: 3.681
Authors: Katie M Phillips; Lloyd P Hoehle; David S Caradonna; Stacey T Gray; Ahmad R Sedaghat Journal: Ann Allergy Asthma Immunol Date: 2016-12 Impact factor: 6.347
Authors: Adam P Campbell; Katie M Phillips; Lloyd P Hoehle; Allen L Feng; Regan W Bergmark; David S Caradonna; Stacey T Gray; Ahmad R Sedaghat Journal: Ann Allergy Asthma Immunol Date: 2017-03 Impact factor: 6.347
Authors: Katie M Phillips; Lloyd P Hoehle; Regan W Bergmark; David S Caradonna; Stacey T Gray; Ahmad R Sedaghat Journal: J Allergy Clin Immunol Pract Date: 2016-11-07
Authors: Marlene M Speth; Lloyd P Hoehle; Katie M Phillips; David S Caradonna; Stacey T Gray; Ahmad R Sedaghat Journal: Ann Allergy Asthma Immunol Date: 2018-06-01 Impact factor: 6.347
Authors: Raphael G Banoub; Katie M Phillips; Lloyd P Hoehle; David S Caradonna; Stacey T Gray; Ahmad R Sedaghat Journal: Laryngoscope Date: 2017-09-30 Impact factor: 3.325
Authors: Samuel D Racette; Alexander L Schneider; Meera Ganesh; Julia H Huang; David S Lehmann; Caroline P E Price; Samuel G Rodegherio; Abhita T Reddy; Jacob G Eide; David B Conley; Kevin C Welch; Robert C Kern; Stephanie Shintani-Smith; Atsushi Kato; Robert P Schleimer; Bruce K Tan Journal: Int Forum Allergy Rhinol Date: 2022-04-01 Impact factor: 5.426
Authors: Mikko Nuutinen; Annina Lyly; Paula Virkkula; Maija Hytönen; Elmo Saarentaus; Antti Mäkitie; Aarno Palotie; Paulus Torkki; Jari Haukka; Sanna Toppila-Salmi Journal: Clin Transl Allergy Date: 2022-07-21 Impact factor: 5.657